Advanced Genetic Technologies Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Advanced Genetic Technologies General Information

Description

Developer of technologies for immune therapy to address the problem of multidrug resistant strains of HIV. The company holds the exclusive licenses for monoclonal antibodies TS1-18 and TS1-22 and non-exclusive rights to the bacterial plasmid 8630.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2109 East Palm Avenue
  • Tampa, FL 33605
  • United States
Primary Industry
Biotechnology
Acquirer
Cytodyn
Vertical(s)
Life Sciences
Corporate Office
  • 2109 East Palm Avenue
  • Tampa, FL 33605
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Advanced Genetic Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Advanced Genetic Technologies‘s full profile, request access.

Request a free trial

Advanced Genetic Technologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Advanced Genetic Technologies‘s full profile, request access.

Request a free trial

Advanced Genetic Technologies FAQs

  • When was Advanced Genetic Technologies founded?

    Advanced Genetic Technologies was founded in 2006.

  • Where is Advanced Genetic Technologies headquartered?

    Advanced Genetic Technologies is headquartered in Tampa, FL.

  • What industry is Advanced Genetic Technologies in?

    Advanced Genetic Technologies’s primary industry is Biotechnology.

  • Is Advanced Genetic Technologies a private or public company?

    Advanced Genetic Technologies is a Private company.

  • What is Advanced Genetic Technologies’s current revenue?

    The current revenue for Advanced Genetic Technologies is .

  • Who are Advanced Genetic Technologies’s investors?

    Innovaro has invested in Advanced Genetic Technologies.

  • When was Advanced Genetic Technologies acquired?

    Advanced Genetic Technologies was acquired on 30-Jan-2007.

  • Who acquired Advanced Genetic Technologies?

    Advanced Genetic Technologies was acquired by Cytodyn.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »